367 Insulin-like
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Organohalogen compounds | 1 | 0.0 | 71× | not tested | |
| Organosulfur compounds | 3 | 0.1 | 30× | not tested | |
| Benzenoids | 4 | 0.4 | 11× | not tested | |
| Phenylpropanoids and polyketides | 1 | 0.1 | 9.75× | not tested | |
| Organic nitrogen compounds | 1 | 0.2 | 6.36× | not tested | |
| Homogeneous non-metal compounds | 5 | 1.1 | 4.71× | not tested | |
| Lipids and lipid-like molecules | 2 | 0.6 | 3.64× | not tested | |
| Organic acids and derivatives | 2 | 0.8 | 2.62× | not tested | |
| Organic oxygen compounds | 2 | 1.0 | 2.04× | not tested | |
| Homogeneous metal compounds | 4 | 2.4 | 1.65× | not tested | |
| Organoheterocyclic compounds | 1 | 0.8 | 1.32× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03255 | IPH | Phenol | 241 |
| DB01776 | CRS | M-Cresol | 87 |
| DB08839 | SRO | Serotonin | 83 |
| DB11085 | RCO | Resorcinol | 78 |
| DB03904 | URE | Urea | 22 |
| DB00125 | ARG | Arginine | 14 |
| DB04066 | HC4 | p-Coumaric acid | 9 |
| DB03556 | PE5 | 2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400 | 6 |
| DB02643 | C15 | N-Dodecyl-N,N-Dimethyl-3-Ammonio-1-Propanesulfonate | 4 |
| DB03733 | DCE | Ethylene Dichloride | 4 |
| DB08231 | MYR | Myristic acid | 4 |
| DB00141 | NAG | N-Acetylglucosamine | 2 |
| DB00316 | TYL | Acetaminophen | 2 |
| DB03175 | POL | Propyl alcohol | 2 |
| DB14212 | MPB | Methylparaben | 2 |
| DB01890 | CPQ | N,N-Bis(3-(D-gluconamido)propyl)deoxycholamide | 1 |
| DB02159 | PGR | (R)-Propylene glycol | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| ZNmetal | ZINC ION | 555 |
| CL | CHLORIDE ION | 359 |
| IPH | PHENOL | 248 |
| CRS | M-CRESOL | 96 |
| SRO | SEROTONIN | 82 |
| RCO | RESORCINOL | 78 |
| SCN | THIOCYANATE ION | 31 |
| NAmetal | SODIUM ION | 27 |
| CUmetal | COPPER (II) ION | 23 |
| URE | UREA | 21 |
| ARG | ARGININE | 14 |
| CAmetal | CALCIUM ION | 12 |
| IS8 | isothiocyanate | 12 |
| NAG | 2-acetamido-2-deoxy-beta-D-glucopyranose | 11 |
| HC4 | 4'-HYDROXYCINNAMIC ACID | 9 |
| NImetal | NICKEL (II) ION | 7 |
| COmetal | COBALT (II) ION | 6 |
| PE5 | 3,6,9,12,15,18,21,24-OCTAOXAHEXACOSAN-1-OL | 6 |
| 16E | N-(16-Carboxyhexadecanoyl)-L-glutamic acid | 4 |
| C15 | N-DODECYL-N,N-DIMETHYL-3-AMMONIO-1-PROPANESULFONATE | 4 |